Investigating a new way the retina processes light during development
Transducin and melanopsin independent phototransduction in postnatal retinal development
This study is looking at how some special cells in the eye can still respond to light in a different way, which might help us learn more about how vision develops and find new treatments for vision problems, especially in young children.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project ID | NIH-10918303 on NIH RePORTER |
What this research studies
This research explores how certain retinal cells respond to light without relying on traditional phototransduction pathways. It focuses on a novel mechanism called transducin- and melanopsin-independent phototransduction (TMIP), which has been observed in genetically modified mice. The study aims to identify the cellular origins of TMIP and its role in the development of vision, particularly during the postnatal period when conventional light processing is not yet fully functional. By understanding this process, researchers hope to uncover new insights into retinal development and potential treatments for vision disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic conditions affecting retinal function or those experiencing developmental vision issues.
Not a fit: Patients with fully developed and functioning retinas or those without any retinal disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating vision impairments related to retinal development.
How similar studies have performed: While the concept of TMIP is novel, similar research has shown promise in understanding alternative pathways of light processing in the retina.
Where this research is happening
San Antonio, United States
- University of Texas Hlth Science Center — San Antonio, United States (Active)
Researchers
- Principal investigator: Chen, Ching-Kang Jason — University of Texas Hlth Science Center
- Study coordinator: Chen, Ching-Kang Jason
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.